🔗 Share this article

An underground economy for unlicensed weight-loss medications is being driven by social media fitness personalities and vendors on messaging platforms, according to new investigations.

Experimental Drug Gaining Popularity Online

The experimental drug, which is still in clinical trials, is being advertised by social media influencers for its supposed fat-burning effects. Followers are encouraged to contact these profiles privately for source information, while also obtaining discount codes.

Active Trade on Social Networks

Separately, a robust trade exists on Telegram, where communities with numerous of members share comparison images, injection guides and claims of rapid UK delivery. Sellers market the substance there before directing buyers to other platforms for purchases.

Learning About Retatrutide

Retatrutide is an investigational injection developed by US drugmaker Eli Lilly. The drug affects three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials indicate it could help patients reduce up to 25% of their body weight. Referred to as the “triple G”, the substance is being promoted online as the successor to Ozempic.

Medical Professionals Express Worries

Nevertheless, physicians and pharmacists have warned that the sale of what remains an unlicensed medication in the United Kingdom is worrisome and could result in individuals administering substances of uncertain source.

Several professionals stated the demand for the experimental drug could be connected to the rising cost of licensed slimming products such as Mounjaro.

Regulatory Position and Enforcement

Marketing the unapproved drug on social media or messaging apps is prohibited in the United Kingdom, as it is an unapproved medication that cannot be promoted or distributed for human use under the Human Medicines Regulations 2012.

Several content creators try to circumvent the regulations by referring to the substance as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled drug, but advertising and distribution can still breach pharmaceutical, advertising, and customer regulations, risking fines, legal action or imprisonment.

Service Response and Material Removal

Based on TikTok, the platform has taken down problematic material and prohibited associated keywords and query recommendations. The organization stated it was committed to keeping the platform secure and allocating resources in enhancing enforcement strategies.

Digital Trading Activities

Investigations also found communities with up to 9,000 participants marketing retatrutide using the platform's built-in search feature, which operates like a online catalog. Entering “retatrutide” instantly brings up channels with thousands of users, populated with photos of slimming results, glowing reviews and step-by-step instructions for mixing or administering at home.

After moments of entering one group, a vendor shared WhatsApp details, where most purchases occur. The vendor sent an guidebook and promised shipping within 48 hours. When asked whether the product was authentic, one seller responded: “You can’t be sure.” Another provided a photo of a supposed testing documentation. Not one asked about weight, health issues or previous experience.

Item Details and Costs

Within these communities, posts display dark colored packages with Royal Mail labels, claiming to include new batches. One communication read: “It took eight of us to load them this morning.”

Customers can choose between dry substance containers, mixed at home with sterile water, or ready-to-use injectors usually sold at 160 pounds for 20 milligrams. When asked how much time a pen should be used, vendors give contradictory answers ranging from a few weeks to “depends on your body”.

Service Moderation and Safety Measures

A spokesperson for Telegram said it actively monitored dangerous content on its platform including material that encouraged the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.

Healthcare Professional Warnings

“Individuals are injecting substances they cannot confirm. Although the science behind retatrutide is sound, these online products may not include what they advertise,” said Jason Murphy, the head of pharmaceutical services at Chemist4U.

Dr Crystal Wyllie of an online medical service connected the surge in interest to recent price rises for authorized weight-loss medications such as Mounjaro. “With costs increasing, patients are turning to online platforms. But counterfeit injections are extremely dangerous. You cannot know what’s contained or whether the environment they were made in was sterile,” she explained.

Her team has previously encountered patients harmed by self-injection from unverified sources. “We understand the frustration, but purchasing from messaging apps or communication platforms is gambling with your well-being,” stated the doctor. “These substances could be impure or improperly measured.”

Producer Position

A representative from the pharmaceutical company said the substance was in third stage clinical trials and had not been evaluated or authorized by any government authority anywhere in the world. “Consequently at this point no one can market [it] for personal consumption,” they explained, adding that any item “misleadingly claiming itself as a company investigational product not yet approved … may subject users to possibly serious health risks”.